Rotigotine extended release - Luye Pharma Group
Alternative Names: Jinyouping; LY-03003; LY-03009; Rotigotine extended release; Rotigotine Microspheres for InjectionLatest Information Update: 15 Nov 2024
At a glance
- Originator Luye Pharma Group
- Class Antiparkinsonians; Small molecules; Tetrahydronaphthalenes; Thiophenes
- Mechanism of Action Dopamine D2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Parkinson's disease
- Phase I Restless legs syndrome